Sharps Technology (STSS) and Its Competitors Critical Analysis

Sharps Technology (NASDAQ:STSS) is one of 234 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it compare to its rivals? We will compare Sharps Technology to related companies based on the strength of its dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Profitability

This table compares Sharps Technology and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sharps Technology	N/A	-102.25%	-72.97%
Sharps Technology Competitors	-673.57%	-130.38%	-27.83%

Volatility & Risk

Sharps Technology has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Sharps Technology’s rivals have a beta of 0.98, indicating that their average stock price is 2% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations for Sharps Technology and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sharps Technology	0	0	0	0	N/A
Sharps Technology Competitors	1695	4493	8666	234	2.49

As a group, “Surgical & medical instruments” companies have a potential upside of 29.91%. Given Sharps Technology’s rivals higher possible upside, analysts plainly believe Sharps Technology has less favorable growth aspects than its rivals.

Insider & Institutional Ownership

17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 48.2% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 12.6% of Sharps Technology shares are held by company insiders. Comparatively, 15.5% of shares of all “Surgical & medical instruments” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Sharps Technology and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sharps Technology	N/A	-$9.84 million	-0.46
Sharps Technology Competitors	$1.03 billion	$3.51 million	-4,293.33

Sharps Technology’s rivals have higher revenue and earnings than Sharps Technology. Sharps Technology is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Sharps Technology rivals beat Sharps Technology on 6 of the 9 factors compared.

About Sharps Technology

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.